National and State Estimates of SELECT Trial Eligibility and Its Public Health Impact in the US.

国家和州对 SELECT 试验资格的估计及其在美国的公共卫生影响。

• 影响指数: 13.353
• 发表时间: 2024 Jul 1
• 来源期刊: JAMA Netw Open
• DOI: 10.1001/jamanetworkopen.2024.20105
• PMID: 38958980
• 文章类型: Journal Article
• 作者列表: Erhabor J,Khorsandi M,Blaha MJ

Mesh: Humans; United States; Public Health; Eligibility Determination; Clinical Trials as Topic; Male; Female

Abstract

This cross-sectional study of US adults examines the geographical distribution of individuals eligible to participate in the Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT) trial to estimate potential cardiovascular health impacts of implementing the trial findings at state and national levels.

摘要

这项针对美国成年人的横断面研究调查了有资格参加塞马鲁肽对超重或肥胖患者心脏病和中风的影响（SELECT）试验的个体的地理分布，以评估在州和州实施试验结果的潜在心血管健康影响。国家级别。